Related Experiment Video
Updated: Jun 24, 2025
13:56
A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
Published on: July 18, 2013
11.2K
HPV integration and cervical cancer: a failed evolutionary viral trait
Mariano A Molina1, Renske D M Steenbergen1, Anna Pumpe2
1Department of Pathology, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; Cancer Centre Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Trends in Molecular Medicine
|June 9, 2024
Summary
Human papillomavirus (HPV) integration into the host genome, while linked to cervical cancer, may paradoxically hinder viral replication. This study explores HPV integration mechanisms and oncogenic transformation.
Area of Science:
- Oncology
- Virology
- Genetics
Background:
- Cervical cancer remains a significant global health burden, despite vaccination and screening efforts.
- Persistent high-risk human papillomavirus (HPV) genotypes, particularly HPV 16 and 18, are primary causes of cervical cancer.
- HPV infection can lead to viral DNA integration into the host genome.
Purpose of the Study:
- To elucidate the mechanisms of HPV integration into the host genome.
- To understand how HPV integration contributes to oncogenic transformation.
- To re-evaluate the role of HPV integration in viral evolution and pathogenesis.
Main Methods:
- Review of existing literature on HPV integration.
- Analysis of molecular mechanisms underlying HPV DNA integration.
- Exploration of the link between HPV integration and cancer development.
Main Results:
- HPV integration is a key event in oncogenesis, but it can impair viral replication and spread.
- This integration represents a potentially 'failed' evolutionary strategy for the virus.
- Specific mechanisms of integration and their role in cellular transformation are detailed.
Conclusions:
- HPV integration is a critical step in cervical cancer development.
- Understanding HPV integration offers insights into viral evolution and potential therapeutic targets.
- The process highlights a complex interplay between viral strategy and host-cell manipulation.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
01:51Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
00:36Viral Mutations
32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
00:57Viral Recombination
23.4K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.4K
01:30Cancer Vaccines
354
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
354
02:21Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K